Supira Medical
PrivateLast Round
Series E
Mar 26, 2025
Est. Valuation
$420M
Total Funding Raised
$240.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Supira Medical is a medical device company that develops percutaneous ventricular assist devices (pVAD) to provide temporary mechanical support for patients experiencing cardiogenic shock or undergoing high-risk percutaneous coronary interventions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Supira Medical Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Supira Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Mar 26, 2025 | ||||
| Series D | Nov 21, 2023 | ||||
| Series C | Feb 28, 2022 | ||||
| Series B | Feb 25, 2020 | ||||
| Series A | Apr 25, 2018 |
Supira Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shifamed | Series C, Series D, Series B, Series A |
| Cormorant Asset Management | Series A, Series E, Series C, Series D, Series B |
| 415 | Series C, Series B, Series E |
| 415 Capital | Series C, Series D, Series B, Series E |
| Unorthodox Ventures | Series D, Series E |
| Cormorant Capital | Series E |
| The Capital Partnership | Series B, Series E, Series C, Series D, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 8, 2026
D. Keith Grossman appointed to the Board of Directors.
- Apr 8, 2026
Received FDA approval to initiate the SUPPORT II Pivotal Trial for its pVAD.
Supira Medical Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Supira Medical's valuation, stock price, and market status.